Effect of a synthetic osteoconductive bone graft substitute with zeta potential control (geneX®ds) in the treatment of intertrochanteric fracture: A single center experience of 115 consecutive proximal femoral nail antirotations

• The study showed that sliding distance at 1, 3, and 12 months follow-up in the geneX^®ds unstable fracture group was significantly shorter than that in the no geneX^®ds group when anatomical or extramedullary reduction was achieved postoperatively.
• The study data showed that any complications, including sterile inflammation, wound dehiscence, the infection, delayed wound healing and local pain related to the use of geneX^®ds were not identified.
• The author states that “Our findings suggest that the use of a synthetic osteoconductive bone graft substitute with zeta potential control may have a positive effect on the controlled sliding of the helical blade and the fracture healing of intertrochanteric fractures”.
• Confirmed bone union was achieved in 97.4% (227) of patients